Meiragtx Holdings Plc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$13.25

+0.20 (+1.53%)

As of Sep 20, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +375.5% upside

Low Target $47.40

Average Target $63.01

High Target $83.78

Current Price $13.25

Current
$13.25

Target
$63.01

$47.40 $63.01 avg $83.78

Scenario Analysis

Bear Case

$47.40

257.7%

Low target

Base Case

$63.01

+375.5%

Avg target

Bull Case

$83.78

+532.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$15.35

-13.7% from high

52-Week Low

$6.62

+100.2% from low

Target vs 52W High

$63.01

+310.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.6%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.5%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%